J. M. Cameron

4.7k citations

35 papers · 3.9k indexed · 1 hit paper · h-index 23

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 16
- HIV Research and Treatment 15
Infectious Diseases 18
- HIV/AIDS drug development and treatment 15
- HIV/AIDS Research and Interventions 4

Co-authors: Charles R. Penn N. Cammack Mark A. Wainberg Richard C. Bethell Wen‐Yang Wu Betty Jin Jeffrey C. Dyason Stuart W. Oliver
Journals: Antimicrobial Agents and Chemotherapy (6 papers)Journal of General Virology (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Biochemical Pharmacology (2 papers)AIDS (2 papers)
Partner nations: United Kingdom Canada United States

In The Last Decade

J. M. Cameron

35 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Rational design of potent sialidase-based inhibitors of influenza virus replication 1993 · 1.5k citations

Peers

Countries citing papers authored by J. M. Cameron

Since Specialization

Citations

This map shows the geographic impact of J. M. Cameron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. Cameron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. Cameron more than expected).

Fields of papers citing papers by J. M. Cameron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. Cameron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. Cameron. The network helps show where J. M. Cameron may publish in the future.

Co-authors

The 25 scholars most cited alongside J. M. Cameron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. M. Cameron Line = papers co-authored together J. M. Cameron links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Recent developments in the design of antiviral agents Medicinal Research Reviews ·John Saunders, J. M. Cameron	1995	14
2	The intracellular phosphorylation of (−)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase γ Biochemical Pharmacology ·Norman M. Gray, Clara L.P. Marr, Charles R. Penn, J. M. Cameron, Richard C. Bethell	1995	65
3	Development of HIV-1 resistance to (−)2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complex AIDS ·Mark A. Wainberg, Horacio Salomón, Zhengxian Gu, Julio Montaner, Timothy P. Cooley, Ronald P. McCaffrey, John Ruedy, Hilary M. Hirst, Nick Cammack, J. M. Cameron, Wendy Nicholson	1995	95
4	Development of HIV-1 resistance to (−)2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complex AIDS ·Mark A. Wainberg, Horacio Salomón, Zhengxian Gu, Julio Montaner, Timothy P. Cooley, Ronald P. McCaffrey, John Ruedy, Hilary M. Hirst, Nick Cammack, J. M. Cameron, Wendy Nicholson	1995	83
5	Susceptibility in cell culture of feline immunodeficiency virus to eighteen antiviral agents Journal of Antimicrobial Chemotherapy ·Neil Smyth, Chelsea McCracken, R. M. Gaskell, J. M. Cameron, Jonathon Alexis Coates, C. J. Gaskell, C. A. Hart, Malcolm J. Bennett	1994	15
6	Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine Antimicrobial Agents and Chemotherapy ·Zhengxian Gu, Qing Gao, Hengsheng Fang, Horacio Salomón, Michael A. Parniak, E.E. Goldberg, J. M. Cameron, Mark A. Wainberg	1994	191
7	Rational design of potent sialidase-based inhibitors of influenza virus replication Nature ·Mark von Itzstein, Wen‐Yang Wu, Gaik B. Kok, Michael S. Pegg, Jeffrey C. Dyason, Betty Jin, Tho van Phan, Mark L. Smythe, Hume F. White, Stuart W. Oliver, Peter M. Colman, Joseph Varghese, David Ryan, Jacqueline M. Woods, Richard C. Bethell, Vanessa J. Hotham, J. M. Cameron, Charles R. Penn Hit paper breakdown →	1993	1465
8	High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase Antimicrobial Agents and Chemotherapy ·Charles A. Boucher, N. Cammack, P Schipper, Rob Schuurman, Philippa Rouse, Mark A. Wainberg, J. M. Cameron	1993	263
9	Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidine Biochemical Pharmacology ·N. Cammack, Philippa Rouse, Clara L.P. Marr, Paula J. Reid, Richard Boehme, Jonathan A. Coates, Charles R. Penn, J. M. Cameron	1992	98
10	DNA chain termination activity and inhibition of human immunodeficiency virus reverse transcriptase by carbocyclic 2',3'-didehydro-2',3'-dideoxyguanosine triphosphate. Journal of Biological Chemistry ·David Orr, HERMIA FIGUEIREDO, C.L. Mo, Charles R. Penn, J. M. Cameron	1992	28
11	Hydrolysis of a Series of Synthetic Peptide Substrates by the Human Rhinovirus 14 3C Proteinase, Cloned and Expressed in Escherichia coli Journal of General Virology ·David Orr, Anna C. J. Long, John Kay, Ben M. Dunn, J. M. Cameron	1989	39
12	A consensus sequence for substrate hydrolysis by rhino virus 3C proteinase FEBS Letters ·Audrey C. Long, David Orr, J. M. Cameron, Ben M. Dunn, John Kay	1989	34
13	Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression Journal of Virology ·C I, Thomas McKee, Jane Ryan, J. M. Cameron, Chris M. Preston	1989	206
14	Ribonucleotide Reductase Encoded by Herpes Simplex Virus Is a Determinant of the Pathogenicity of the Virus in Mice and a Valid Antiviral Target Journal of General Virology ·J. M. Cameron, I. Ross McDougall, H. S. Marsden, V. G. Preston, D. M. Ryan, J. H. Subak‐Sharpe	1988	127
15	Severe tubulo-interstitial disease in a renal allograft due to cytomegalovirus infection. PubMed ·J. M. Cameron, Rigby Rj, van Deth Ag, Petrie Jj	1982	32
16	Ideology and policy termination: restructuring California's mental health system. PubMed ·J. M. Cameron	1978	26
17	Inhibition of cell division in amoebae: the incorporation of tritiated precursors into Amoeba proteus after the injection of non-homologous cytoplasm Journal of Cell Science ·J. M. Cameron, Shirley E. Hawkins	1976	5
18	Nuclear transfer studies of amoeba proteus after the inhibition of cell division by injection of non-homologous cytoplasm Biochemical and Biophysical Research Communications ·J. M. Cameron, Shirley E. Hawkins	1973	1
19	The Statistical Consultant in a Scientific Laboratory Technometrics ·J. M. Cameron	1969	16
20	The Use of Components of Variance in Preparing Schedules for Sampling of Baled Wool Biometrics ·J. M. Cameron	1951	22

About J. M. Cameron

J. M. Cameron is a scholar working on Virology, Infectious Diseases, Aging, Epidemiology and Transplantation, having authored 35 papers that have together received 3.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (15 papers), Cytomegalovirus and herpesvirus research (8 papers), Biochemical and Molecular Research (5 papers), Herpesvirus Infections and Treatments (5 papers), HIV/AIDS Research and Interventions (4 papers), Virus-based gene therapy research (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). The work is most often cited by research in Virology (1.3k citations), Infectious Diseases (1.8k citations), Epidemiology (1.7k citations), Hepatology (250 citations) and Organic Chemistry (635 citations). J. M. Cameron has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Charles R. Penn, N. Cammack, Mark A. Wainberg, Richard C. Bethell, Wen‐Yang Wu, Betty Jin, Jeffrey C. Dyason, Stuart W. Oliver, Mark von Itzstein and Peter M. Colman. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of General Virology, Bioorganic & Medicinal Chemistry Letters, Biochemical Pharmacology and AIDS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact